Wells Fargo’s AstraZeneca AZN Stock Holding History

Wells Fargo’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.37M	Sell	12,000 -1,150	-9%	-$222K	﹤0.01%	3143
2025 Q4	$2.42M	Sell	13,150 -800	-6%	-$140K	﹤0.01%	3290
2025 Q3	$2.14M	Buy	13,950 +12,000	+615%	+$1.82M	﹤0.01%	3257
2025 Q2	$273K	Buy	+1,950	New	+$273K	﹤0.01%	4577
2025 Q1	–	Sell	-117,850	Closed	-$15.4M	–	7035
2024 Q4	$15.4M	Buy	+117,850	New	+$16.5M	﹤0.01%	1530
2023 Q1	–	Sell	-50,000	Closed	-$6.78M	–	7669
2022 Q4	$6.78M	Hold	50,000	–	–	﹤0.01%	1830
2022 Q3	$5.48M	Hold	50,000	–	–	﹤0.01%	1926
2022 Q2	$6.61M	Hold	50,000	–	–	﹤0.01%	1875
2022 Q1	$6.63M	Buy	50,000 +49,950	+99,900%	+$5.99M	﹤0.01%	2203
2021 Q4	$6K	Buy	+50	New	+$5.88K	﹤0.01%	6660
2021 Q1	–	Sell	-37,500	Closed	-$568K	–	6875
2020 Q4	$568K	Sell	37,500 -7,500	-17%	-$794K	﹤0.01%	4430
2020 Q3	$431K	Buy	45,000 +7,200	+19%	+$801K	﹤0.01%	4457
2020 Q2	$93K	Buy	+37,800	New	+$3.9M	﹤0.01%	5252
2017 Q3	–	Sell	-3,600	Closed	-$7K	–	6303
2017 Q2	$7K	Buy	+3,600	New	+$235K	﹤0.01%	5848
2015 Q1	–	Sell	-250,000	Closed	-$52K	–	6159
2014 Q4	$52K	Hold	250,000	–	–	﹤0.01%	4997
2014 Q3	$263K	Hold	250,000	–	–	﹤0.01%	4228
2014 Q2	$18.6M	Buy	+250,000	New	+$18.1M	0.01%	1348

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Wells Fargo's AZN Position: Q1 2026 in Review

Wells Fargo reduced its AstraZeneca (AZN) stake by 0.44% in Q1 2026, selling an estimated $1.31M and leaving 1,544,632 shares worth $305M. The position accounts for 0.06% of the portfolio, ranked #280.

Wells Fargo first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Wells Fargo held 1,544,632 shares of AstraZeneca worth $305M as of Q1 2026.
Wells Fargo sold 6,794 AstraZeneca shares in Q1 2026, an estimated $1.31M.
AstraZeneca made up 0.06% of Wells Fargo's portfolio in Q1 2026, its #280 holding.
Wells Fargo first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.